Intrexon | XON - Ebitda





Ebitda Perubahan Tanggal
Agenus USD -10.11M 19.02M 2025-03
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Amgen USD 4.55B 696M 2026-06
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD -147.68M 40.33M 2026-06
AstraZeneca USD 7.46B 2.3B 2026-09
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Gilead Sciences USD -9.31B 12.82B 2026-06
GlaxoSmithKline GBP 3.51B 734M 2026-06
Heron Therapeutics USD -3.88M 5.63M 2024-09
Incyte USD 778.57M 410.6M 2026-06
Intrexon USD -24.7M 2.92M 2024-06
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Ligand Pharmaceuticals USD 74.27M 88.56M 2026-06
MacroGenics USD -64.54M 34.34M 2026-06
MannKind USD 2.93M 5.98M 2026-03
Merck USD 1.42B 2.97B 2026-06
Novartis USD 8.62B 2.14B 2026-09
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Roche Holding CHF 13.43B 744M 2026-06
Thermo Fisher Scientific USD 3.79B 244M 2026-09
Veracyte USD 43.96M 1.16M 2026-06
Xencor USD -34.63M 86.74M 2026-06